FactorPad
FinTech Dev and Data

Stock Risk Measures for Bio-Rad Laboratories-A

A quantitative factor review, as of July 31, 2020.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
by Paul Alan Davis, CFA
Updated: August 02, 2020
See how we arrive at an overall risk score of 25 for BIO below.

/ factorpad.com / stocks / f39thw.html



BIO Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Bio-Rad Laboratories-A. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how BIO stock compares to 2,000+ US-based stocks, and to peers in the Health Technology sector and Medical Specialties industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Identity

Sector and Industry

Share Data

Shares and Float

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f39thw.html


BIO stock risk
BIO-RAD LABORATORIES-A stock beta
BIO risk report
BIO f39thw
BIO risk analysis
BIO volatility
BIO-RAD LABORATORIES-A credit risk
BIO liquidity risk
BIO leverage
BIO valuation
BIO systematic risk
BIO specific risk
BIO-RAD LABORATORIES-A volatility
BIO analysis
BIO financial ratio